A Study of LY2605541 (Insulin Peglispro) and Human Insulin Concentrations in Fat Tissue

NCT02109029 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: Insulin Peglispro
DRUG: Human Insulin

Sponsor

Eli Lilly and Company